Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 111-120 of 195

Page
per page
  1. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  2. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  3. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: Dual inhibitor of tyrosine and phosphoinositide kinases
  4. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  5. PF-4708671
    B2228 PF-4708671
     1 Citation
    Target: p70 rsk
    Summary: P70 S6K1 isoform inhibitor,cell-permeable
      ≥37.8 mg/mL
  6. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  7. A 83-01
    A3133 A 83-01
    Summary: ALK-5 inhibitor
      ≥21.1 mg/mL
  8. Indirubin
    B3672 Indirubin
    Target: Cyclin-Dependent Kinases|GSK-3
    Summary: cyclin-dependent kinases and GSK-3β inhibitor
      insoluble in H2O; insoluble in H2O; insoluble in EtOH; ≥13.1 mg/mL
  9. SB 431542
    A8249 SB 431542
     2 Citation
    Summary: ALK inhibitor
  10. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL

Items 111-120 of 195

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Related Disease Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Apoptosis 5item
  2. Chromatin/Epigenetics 24item
  3. MAPK Signaling 14item
  4. Tyrosine Kinase 79item
  5. DNA Damage/DNA Repair 6item
  6. PI3K/Akt/mTOR Signaling 24item
  7. Cell Cycle/Checkpoint 52item
  8. Ubiquitination/ Proteasome 3item
  9. JAK/STAT Signaling 21item
  10. TGF-β / Smad Signaling 16item
  11. GPCR/G protein 1 item
  12. Stem Cell 3item
  13. Others 5item
  14. Immunology/Inflammation 1 item
Specificity
  1. Selective 153item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 18item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 11item
  5. Raf 9item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 5item
  9. FLT3 7item
  10. GSK-3 4item
  11. PLK 5item
  12. Chk 4item
  13. Eph Receptors 3item
  14. VEGFR 27item
  15. PDGFR 17item
  16. c-Kit 9item
  17. RET 4item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 3item
  20. JNK 1 item
  21. SGK 2item
  22. Bcr-Abl 6item
  23. MEK 2item
  24. FGFR 9item
  25. Pim 3item
  26. Ribosomal s6 kinases (RSK) 1 item
  27. MET 5item
  28. Src 8item
  29. Trk Receptors 1 item
  30. STAT 1 item
  31. EGFR 13item
  32. PAK 3item
  33. FAK 4item
  34. BMP and Other Activin Receptors 1 item
  35. JAK 7item
  36. Syk 3item
  37. DNA-PK 4item
  38. ErbB 4item
  39. ERK 2item
  40. c-MET 5item
  41. PKC 8item
  42. Ubiquitin-specific proteases 1 item
  43. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  44. Lyn 1 item
  45. HER2 1 item
  46. Pyk2 3item
  47. Insulin and Insulin-like Receptors 2item
  48. ALK 5item
  49. ROS1 1 item
  50. Sphingosine kinases (SphKs) 1 item
  51. PKG 2item
  52. PKA 4item
  53. Myosin light chain kinases (MLCKs) 1 item
  54. MELK 1 item
  55. Insulin-like growth factors (IGFs) 1 item
  56. MK2 1 item
  57. Tie-2 1 item
  58. RSK 1 item
  59. ATM/ATR 3item
  60. CK1 1 item
  61. Farnesyl Diphosphate Synthases 1 item
  62. CK2 1 item
  63. HIPK2 1 item
  64. HIPK3 1 item
  65. P110 1 item
  66. Hck 1 item
  67. MNK 1 item
  68. Insulin Receptors 1 item
  69. IRG-1R 1 item
  70. eEF-2 1 item
  71. Cdc7 1 item
  72. ZAP-70 1 item
  73. c-RET 2item
  74. p70 rsk 1 item
  75. VEGFR3/FLT4 1 item
  76. NTRK1/TRKA 1 item
  77. CSF-1R/c-Fms 1 item
  78. TAM kinase 1 item
  79. KDR 1 item
  80. AXL 1 item
  81. insulin 1 item
  82. ErbB-2 1 item
  83. PDK-1 1 item
  84. Prk 1 item
  85. Flk1 2item
  86. tropomyosin receptor kinase 1 item
  87. SK 1 item
  88. PPK 1 item
  89. c-Syk 1 item
  90. CDK1/CyclinB 1 item
  91. PIM1 kinase 1 item
  92. phospholipase A2 1 item
Reported Experiments
  1. Animal Experiments 182item
  2. Cell Experiments 120item